Transpire Bio Announces Opening of New Satellite R&D Facility in Shanghai_ China (original) (raw)

SUNRISE, Fla., April 28, 2026 /PRNewswire/ -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company developing inhaled therapeutics for pulmonary and systemic diseases, has opened its new satellite R&D facility in Shanghai, China. An opening ceremony was held on April 23, 2026, to inaugurate the site,...read full story

"As Transpire Bio continues to execute its strategic plan of building a legacy as an innovator in inhalation-based therapies, we are pleased to announce the grand opening of our Shanghai R&D center,"